Keyphrases
Warfarin
100%
Warfarin Dose
98%
Pharmacogenetics
69%
International Normalized Ratio
55%
Bleeding
51%
Hemophagocytic Lymphohistiocytosis
46%
Warfarin Therapy
43%
Therapeutic Agents
32%
CYP2C9
30%
Proficiency Testing
26%
Warfarin Initiation
26%
Venous Thromboembolism
26%
Genotype
26%
College of American Pathologists
23%
Orthopaedic Patients
22%
Transfusion
21%
Von Willebrand Factor
21%
Clinical Factors
18%
Single nucleotide Polymorphism
18%
Cardiac Surgery
17%
Venous Thromboembolic Disease
17%
Hip or Knee Arthroplasty
17%
External Quality Assurance
17%
Ferritin
17%
Randomized Clinical Trial
16%
Adult Patients
16%
Coagulation
16%
VKORC1
15%
Polymorphism
15%
Heparin
15%
Informatics
15%
Thrombosis
15%
Autoantibodies
14%
Hemostasis
13%
Recombinant Activated Factor VII (rFVIIa)
13%
Clinical Outcomes
13%
Reductase
13%
Cytochrome P450 (CYP450)
12%
Serum Ferritin
12%
Genotype-guided
12%
Optimal Management
12%
Venous Thromboembolic Events
12%
Clinical Algorithm
12%
Vitamin K Epoxide Reductase
12%
Low Intensity
12%
Von Willebrand Disease
11%
Venous Thrombosis
11%
Oncology
11%
Clinical Practice Guidelines
11%
Autoimmune Hemolytic Anemia
11%
Medicine and Dentistry
Bleeding
58%
Hemophagocytic Syndrome
46%
Venous Thromboembolism
36%
Warfarin
31%
Thrombosis
24%
Pathologist
19%
Blood Stasis
17%
Heart Surgery
17%
Knee Arthroplasty
17%
Hip Arthroplasty
17%
Randomized Clinical Trial
14%
Diagnosis
13%
Ferritin
13%
Oncology
13%
Thrombin
12%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Antiphospholipid Syndrome
11%
Hematology
11%
Heart Muscle Injury
11%
Malignant Neoplasm
11%
Von Willebrand Disease
11%
Plasma Cell Dyscrasia
11%
Disease
11%
Heparin
11%
Von Willebrand Factor
11%
Anticoagulation
10%
Platelet
10%
Thromboembolism
9%
Autoantibodies
9%
Laboratory Test
9%
Troponin I
9%
Cardiac Troponin
9%
Multiple Myeloma
8%
Pathophysiology
8%
Transfusion Medicine
8%
Emergency Department
8%
Deep Vein Thrombosis
7%
Autoimmune Disease
7%
Polymerase Chain Reaction
7%
Thrombocytopenia
7%
Ehrlichia
7%
Prognostic Factor
6%
Heparin-Induced Thrombocytopenia
6%
Health Care Cost
6%
Erythrocyte
6%
Tertiary Care
6%
Lymphocyte
6%
Infection
6%
Laboratory Assessment
6%
Thrombophilia
6%
